American biotechnology company that researches, develops and commercializes drugs.
Advocate on drug pricing proposals, including reconciliation legislation, and expanding access to HIV treatment and prevention therapies. Supply Chain. Engage on pharmaceutical policy as it relates to payments under the 340B program. Highlight Gilead's efforts to ensure diversity in clinical trials. Issues related to developing treatments for COVID-19 (2019 Novel Coronavirus). Reauthorization of the Prescription Drug User Fee Act and related issue
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TODD STRATEGY GROUP
1201 New York Avenue, NW, 8th Floor, Washington, DC, 20005, US
PAUL EDATTEL JEFF LUCAS DANIEL M TODD